Vlastníctvo manažmentu spoločnosti Beam Therapeutics
Aká je hodnota metriky Vlastníctvo manažmentu spoločnosti Beam Therapeutics?
Hodnota metriky Vlastníctvo manažmentu spoločnosti Beam Therapeutics Inc. je 1.90%
Aká je definícia metriky Vlastníctvo manažmentu?
Vlastníctvo manažmentu (Insider Ownership) je pomer akcií vlastnených akcionármi v rámci firmy (vlastniaci viac než 5% spoločnosti alebo s titulom riaditeľa či vedúceho oddelenia) a všetkých vydaných akcií.
A high value of insider ownership means that those working for the company have a large stake in the success of the company. This is sometimes seen as a sign that those running the company will work hard to ensure its success or believe the company's stock price will rise.
A change in insider ownership may come from exercise of option, stock grant and buying or selling of company shares. A purchase of company share signifies a confidence in the company's future performance by people who know the company best. Therefore, Net Insider buying is also an important indicator for investors.
Vlastníctvo manažmentu spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou Beam Therapeutics
Čomu sa venuje spoločnosť Beam Therapeutics?
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen receptor T cell for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia. It also develops therapies for alpha-1 antitrypsin deficiency and glycogen storage disorder 1a; and therapies for ocular and central nervous system disorders. The company has a strategic alliance with Boston Children's Hospital; a research and clinical collaboration agreement with Magenta Therapeutics, Inc.; and a research collaboration with the Institute of Molecular and Clinical Ophthalmology Basel. It also has a research collaboration with Apellis Pharmaceuticals, Inc. to apply base editing technology for discovering new treatments for complement-driven diseases. Beam Therapeutics Inc. was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.
Firmy s metrikou vlastníctvo manažmentu podobnou spoločnosti Beam Therapeutics
- Hodnota metriky Vlastníctvo manažmentu spoločnosti Five Below Inc je 1.89%
- Hodnota metriky Vlastníctvo manažmentu spoločnosti Charter Hall Retail Real Estate Investment Trust je 1.89%
- Hodnota metriky Vlastníctvo manažmentu spoločnosti Coherent Corp je 1.89%
- Hodnota metriky Vlastníctvo manažmentu spoločnosti Oxford Immunotec Global PLC je 1.89%
- Hodnota metriky Vlastníctvo manažmentu spoločnosti Silver Lake Resources je 1.90%
- Hodnota metriky Vlastníctvo manažmentu spoločnosti CryoPort Inc je 1.90%
- Hodnota metriky Vlastníctvo manažmentu spoločnosti Beam Therapeutics je 1.90%
- Hodnota metriky Vlastníctvo manažmentu spoločnosti Murata Manufacturing Co je 1.90%
- Hodnota metriky Vlastníctvo manažmentu spoločnosti Vista Outdoor Inc je 1.90%
- Hodnota metriky Vlastníctvo manažmentu spoločnosti Timbercreek je 1.90%
- Hodnota metriky Vlastníctvo manažmentu spoločnosti iRobot je 1.90%
- Hodnota metriky Vlastníctvo manažmentu spoločnosti Cincinnati je 1.90%
- Hodnota metriky Vlastníctvo manažmentu spoločnosti AMBAC je 1.91%